(Reuters) - The test, called the GeneSearch Breast Lymph Node Assay, is
manufactured by Johnson & Johnson unit Veridex LLC.
The molecular-based laboratory test was approved by the FDA
to find cancerous growths in lymph node tissue removed from
breast cancer patients. The aim is to help doctors quickly
decide whether to remove more nodes during surgery, or risk
having the patient undergo a second operation.
Read more at Reuters.com Government Filings News
manufactured by Johnson & Johnson unit Veridex LLC.
The molecular-based laboratory test was approved by the FDA
to find cancerous growths in lymph node tissue removed from
breast cancer patients. The aim is to help doctors quickly
decide whether to remove more nodes during surgery, or risk
having the patient undergo a second operation.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment